The following agenda is for the PEPFAR Scientific Advisory Board Meeting that will take place virtually on November 2-3, 2021.
November 2, 2021 10:00 AM – 2:00 PM (4 hours)
WebEx Information: https://statedept.webex.com/statedept/j.php?MTID=m43c86e83f8236c7d10f485f88f3c256f
Meeting number: 2762 527 0290 Password: U7t6JvN6773 (87865866 from phones) Join by Phone: +1 (415) 527-5035
Agenda Day 1:
| All times EDT | Registration | |
| 10:00–10:15 |
Opening Remarks • Welcome, FACA overview • Introduction of new members • Meeting overview & Board introductions |
Sara Klucking & Carlos del Rio 15’ |
|
10:15–11:00 11:00–11:45 |
PEPFAR 2020/2021 Opening Remarks & Presentation • Performance in COP20, plans for COP21 including efforts to ensure continuities of HIV services in the context of COVID–19. PEPFAR strategies, plans, and program updates going into COP 2022 Comments / Recommendations for PEPFAR action |
Acting U.S. Global AIDSCoordinator Angeli Achrekar 45’/ SAB Members 45’ |
|
11:45– 12:00 |
BREAK | 15’ |
|
12:00–12:35 12:35–1:15 |
COP 2022 Guidance Updates • Focus on Sustained Epidemic Control • Addressing key gaps – kids, AGYW, KP • Minimum Program Requirements • New Monitoring, Evaluation, and Reporting (MER) indicators Comments / Recommendations for PEPFAR action |
TBC SAB Members 20’ |
| 1:15–1:35 | Update on New Biomedical Prevention Products • Implications for PEPFARprograms | Mitchell Warren 20’ |
| 1:35–1:55 | Update on New Long-Acting Treatments • Implications for PEPFAR programs | Carlos del Rio 20’ |
| 1:55–2:00 | Summary Comments & Closing Day 1 | Angeli Achrekar & Carlos del Rio |
November 3, 2021, 10:00 AM – 2:00 PM (4 hours)
WebEx Information: https://statedept.webex.com/statedept/j.php?MTID=mb8206a8b05141171576cf4d3ea09c315
Meeting number: 2761 327 4835 Password: UYucV633642 (89828633 from phones) Join by Phone: +1 (415) 527-5035
Agenda Day 2:
| AllTimesEDT | Registration | |
| 10:00 –10:10 |
Opening Remarks • Welcome, FACA overview • Meeting overview & Board introductions |
Sara Klucking & Carlos del Rio 10’ |
|
10:10 –11:35 11:35 –12:15 |
Technical Considerations – Fifteen minutes for each topic, inclusive of discussion • Use of HIV self–testing to monitor seroconversion in persons taking PrEP • Updates on mortality, advanced disease, and use of CD4 testing • HPV DNA testing as a primary screening method in the Cervical Cancer ScreeningProgram (Go Further) • Use of POC diagnostics and multiplex use of lab instruments for HIV (VL, EID), TB, COVID–19, and HPV. • Updated guidance on mental health services and psychosocial support in PEPFAR treatment continuity in PLHIV o AGYW prevention in DREAMS o Key Populations Comments / Recommendations for PEPFAR action |
TBC SAB Members15’ |
|
12:15– 12:30 |
BREAK | 15’ |
|
12:30 –1:20 1:20 –1:40 |
PEPAFR Implementation Science Comments / Recommendations for PEPFAR action |
TBC SAB Members 20’ |
| 1:40 –1:50 | Public Comments & Questions Other Business | Sara Klucking & Carlos del Rio |
| 1:50 –2:00 | Summary Comments & Closing | Angeli Achrekar & Carlos del Rio |
| 2:00 | Adjourn | Sara Klucking |